Digital Lifestyle Management for Weight Loss Control After Thyroidectomy in Thyroid Cancer Patients

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05126706
Collaborator
(none)
80
1
2
33.6
2.4

Study Details

Study Description

Brief Summary

Thyroid hormones play an important role in the regulation of the body's metabolism. But the relationship between thyroid hormone status and the basal metabolism rate is not absolute. Because thyroid hormone function is not the only factor of control the metabolism and it can be influenced by various factors such as physical activity and diet.

Weight change after thyroidectomy is one of the concerns for thyroid cancer patients. The evidence on the bodyweight changes following thyroidectomy has not been established well. Being overweight and obese can increase the risk of developing many potential health problems, such as heart disease, diabetes, high blood pressure, and malignant disease.

Recently, digital health care technology has been developed and applied for medical purposes in many clinical practices. Digital Lifestyle Management is one of the strategies that can be helpful for the obese to control their body weight by lifestyle modification. It provides comprehensive, multifactorial, intensive interventions which are delivered via the digital health care mobile service Noom application.

The aim of this study is to evaluate the efficacy of digital lifestyle management on body weight and quality of life after total thyroidectomy in thyroid cancer patients by using the digital health care Noom application.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Digital lifestyle management
N/A

Detailed Description

The present study is a prospective randomized control trial. A total of 80 patients who underwent total thyroidectomy for thyroid cancer is included. Fifty-four patients are randomly assigned to the digital lifestyle management group and the other 26 patients are assigned to the non-digital lifestyle management group.

In the experimental group (digital lifestyle management group), the patients will use this application for the first 4 months with Noom applications with 1:1 personalized coaching intervention, and then, use this app by self-help program without coaching intervention. The digital lifestyle management program will record the patient's meals, exercise, steps taken, reading articles, and give feedback to each patient. In order to monitor the psychological state and quality of life of the patients, online questionnaires will be provided.

In the control group (non-digital lifestyle management group), the patients will get the conventional postoperative care protocol without using the Noom application. To investigate the weight change and quality of life, variables are collected at baseline, 4 months, and 6 months after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Validating Efficacy for Digital Lifestyle Management for Weight Loss Control After Thyroidectomy in Thyroid Cancer Patients
Actual Study Start Date :
Nov 12, 2021
Anticipated Primary Completion Date :
Aug 30, 2024
Anticipated Study Completion Date :
Aug 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Digital lifestyle management group

In the experimental group (digital lifestyle management group), 54 patients are randomly assigned to the digital lifestyle management group. The patients use this application for the first 4 months with Noom applications with 1:1 personalized coaching intervention, and then, use this app by self-help program without coaching intervention. In order to monitor the psychological state of the patients, all the patients are given daily assessment online questionnaires and additional questionnaires to evaluate the quality of life at the baseline, 4 months, and 6 months after surgery. To assess the nutritional status of the patients, we collect blood laboratory data, bioimpedance analysis for each visit.

Behavioral: Digital lifestyle management
Digital lifestyle management for Weight Loss Control after Thyroidectomy

No Intervention: Non-digital lifestyle management group

In the control group (Non-digital lifestyle management group), 26 patients are randomly assigned to the control group (Non-digital lifestyle management group). The patients follow conventional postoperative care protocol after total thyroidectomy for thyroid cancer without using Noom application. All patients are given questionnaires to evaluate the quality of life at the baseline, 4 months, and 6 months after surgery. To assess the nutritional status of the patients, we collect blood laboratory data, bioimpedance analysis for each visit.

Outcome Measures

Primary Outcome Measures

  1. Weight change [baseline, 4 months, 6 months]

    Change from baseline weight at 4 months and 6 months after surgery

Secondary Outcome Measures

  1. Changes of results about questionnaires for quality of life (Korean Obesity Quality of Life (KOQOL)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Korean Obesity Quality of Life (KOQOL) Range: 4-60 Higher scores: impaired QOL

  2. Changes of results about questionnaires for quality of life (World Health Organization Quality of Life - Brief Form (WHOQOL-Bref)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # World Health Organization Quality of Life - Brief Form (WHOQOL-Bref) Range: 0-100 Higher scores: higher QOL

  3. Changes of results about questionnaires for quality of life (Pittsburgh Sleep Quality Index (PSQI)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Pittsburgh Sleep Quality Index (PSQI) Range: 0-21 Lower scores: a healthier sleep quality

  4. Changes of results about questionnaires for quality of life (Korean-Beck Depression Inventory-II (K-BDI-II)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Korean-Beck Depression Inventory-II (K-BDI-II) Range: 0-63 Higher scores: Depression

  5. Changes of results about questionnaires for quality of life (State-Trait Anxiety Inventory (STAI)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # State-Trait Anxiety Inventory (STAI) Range: 20-80 Higher scores: anxiety

  6. Changes of results about questionnaires for quality of life (Rosenberg Self-Esteem Scale (RSES)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Rosenberg Self-Esteem Scale (RSES) Range: 0-30 Higher scores: lower self-esteem

  7. Changes of results about questionnaires for quality of life (Body Shape Questionnaire (BSQ-8C) ) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Body Shape Questionnaire (BSQ-8C) Range: 8-48 Higher values: body dissatisfaction

  8. Changes of results about questionnaires for quality of life (Dutch Eating Behaviour Questionnaire (DEBQ)) [baseline, 4 months, 6 months]

    Change from baseline results of questionnaires at 4 months and 6 months after surgery # Dutch Eating Behaviour Questionnaire (DEBQ) Range: 33-165 Higher scores: the eating behavior

  9. Changes of waist circumstance [baseline, 4 months, 6 months]

    Waist circumstance difference

  10. Changes of hip circumstance [baseline, 4 months, 6 months]

    Hip circumstance difference

  11. Changes of body fat percent [baseline, 4 months, 6 months]

    Body fat percent difference

  12. Changes of lean body mass [baseline, 4 months, 6 months]

    Lean body mass difference

  13. Changes of total cholesterol level [baseline, 4 months, 6 months]

    Biological index

  14. Changes of HDL cholesterol level [baseline, 4 months, 6 months]

    Biological index

  15. Changes of LDL cholesterol level [baseline, 4 months, 6 months]

    Biological index

  16. Changes of triglyceride level [baseline, 4 months, 6 months]

    Biological index

  17. Changes of aspartate aminotransferase (AST) level [baseline, 4 months, 6 months]

    Biological index

  18. Changes of alanine aminotransferase (ALT) level [baseline, 4 months, 6 months]

    Biological index

  19. Changes of gamma-glutamyl transferase (GGT) level [baseline, 4 months, 6 months]

    Biological index

  20. Changes of free T3 level [baseline, 4 months, 6 months]

    Biological index

  21. Changes of free T4 level [baseline, 4 months, 6 months]

    Biological index

  22. Changes of TSH level [baseline, 4 months, 6 months]

    Biological index

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Target: Among the patients who have undergone thyroidectomy, patients who are interested in weight management and can use the Noom app by themselves or with the help of neighbors.

  • The patient has 23 or more BMI at the time of enrollment.

  • In The Situational Motivation Scale (SIMS), a total of five stages of synchronization level of 68 or higher, which is the top 40% of the 112 points (1st stage: pre-consumption stage; stage 2: deliberation stage; stage 3: preparation stage; stage 4: action stage)

  • The patient agreed about participating in this study.

Exclusion Criteria:
  • The patient was diagnosed with chronic diseases (hepatic disease, kidney disease, diabetes, etc.).

  • In the case where there is no member who can support among family members,

  • The patient who is not a smartphone or has difficulty using digital technology.

  • When it is difficult to lose weight (pregnancy and pregnancy preparation, breastfeeding, and less than 12 months after childbirth)

  • If the patient has a history of psychiatric illness (eating disorder, depression, etc.).

  • If the patient is taking diet-related drugs or health supplements, or treatments.

  • If there is a restriction on physical activity (not allowed to exercise for more than 30 minutes a day).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of 110-744

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Principal Investigator: Kyu Eun Lee, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kyu Eun Lee, Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05126706
Other Study ID Numbers:
  • 2105-192-1224
First Posted:
Nov 19, 2021
Last Update Posted:
Nov 19, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kyu Eun Lee, Professor, Seoul National University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 19, 2021